• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[免疫组织化学在胰腺神经内分泌肿瘤中的实际应用:技巧与陷阱]

[Practical application of immunohistochemistry in pancreatic neuroendocrine neoplasms : Tips and pitfalls].

作者信息

Bräutigam Konstantin, Chouchane Aziz, Konukiewitz Björn, Perren Aurel

机构信息

Institut für Gewebemedizin und Pathologie, Universität Bern, Murtenstr. 31, 3008, Bern, Schweiz.

Institut für Pathologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Christian-Albrechts-Universität zu Kiel, Kiel, Deutschland.

出版信息

Pathologie (Heidelb). 2024 Feb;45(1):35-41. doi: 10.1007/s00292-023-01276-4. Epub 2024 Jan 4.

DOI:10.1007/s00292-023-01276-4
PMID:38175232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10827836/
Abstract

Pancreatic neuroendocrine neoplasms (PanNEN) are rather rare entities. Morphology, combined with immunohistochemistry, allows typing and grading, thereby leading therapeutic decisions. Depending on tumor stage and differential diagnosis, a broad diagnostic panel may be required. The present work summarizes the minimal diagnostic, prognostic, and predictive markers in PanNEN.Markers of choice for defining a neuroendocrine phenotype are synaptophysin, chromogranin A, and INSM1. The proliferation fraction Ki67 is indispensable for grading, while p53 and Rb1 can help in the differentiation from neuroendocrine carcinoma (NEC). Transcription factors, such as cdx2, TTF‑1, and Islet‑1, can indicate the site of a primary tumor in the setting of a cancer of unknown primary (CUP). DAXX/ATRX immunohistochemistry has mainly prognostic value. Molecular pathology studies currently have little practical value in the diagnosis of PanNEN.An important pitfall in routine diagnostics is the wide spectrum of differential diagnoses mimicking neuroendocrine neoplasms. An expanded immunohistochemical panel is strongly recommended in case of doubt.

摘要

胰腺神经内分泌肿瘤(PanNEN)是相当罕见的疾病。形态学结合免疫组织化学可进行分型和分级,从而指导治疗决策。根据肿瘤分期和鉴别诊断,可能需要一套广泛的诊断指标。本研究总结了PanNEN中最低限度的诊断、预后和预测标志物。用于定义神经内分泌表型的首选标志物是突触素、嗜铬粒蛋白A和胰岛素瘤相关蛋白1(INSM1)。增殖分数Ki67对于分级必不可少,而p53和视网膜母细胞瘤蛋白1(Rb1)有助于与神经内分泌癌(NEC)相鉴别。转录因子,如尾型同源盒转录因子2(cdx2)、甲状腺转录因子1(TTF-1)和胰岛1(Islet-1),可在原发灶不明的癌症(CUP)情况下指示原发肿瘤的部位。死亡结构域相关蛋白(DAXX)/α地中海贫血伴智力低下综合征X连锁基因(ATRX)免疫组织化学主要具有预后价值。分子病理学研究目前在PanNEN的诊断中实用价值不大。常规诊断中的一个重要陷阱是存在一系列模仿神经内分泌肿瘤的鉴别诊断。如有疑问,强烈建议使用扩展的免疫组织化学指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85f0/10827836/22c6fcc40706/292_2023_1276_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85f0/10827836/241585c19b55/292_2023_1276_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85f0/10827836/77ae5801aaab/292_2023_1276_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85f0/10827836/4d9a18ab1d1a/292_2023_1276_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85f0/10827836/22c6fcc40706/292_2023_1276_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85f0/10827836/241585c19b55/292_2023_1276_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85f0/10827836/77ae5801aaab/292_2023_1276_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85f0/10827836/4d9a18ab1d1a/292_2023_1276_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85f0/10827836/22c6fcc40706/292_2023_1276_Fig4_HTML.jpg

相似文献

1
[Practical application of immunohistochemistry in pancreatic neuroendocrine neoplasms : Tips and pitfalls].[免疫组织化学在胰腺神经内分泌肿瘤中的实际应用:技巧与陷阱]
Pathologie (Heidelb). 2024 Feb;45(1):35-41. doi: 10.1007/s00292-023-01276-4. Epub 2024 Jan 4.
2
Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls.胰腺神经内分泌肿瘤:诊断与陷阱。
Virchows Arch. 2022 Feb;480(2):247-257. doi: 10.1007/s00428-021-03211-5. Epub 2021 Oct 13.
3
A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.胰腺WHO 3级(G3)高分化神经内分泌肿瘤(WD-NET)和低分化神经内分泌癌(PD-NEC)分类的实用方法
Am J Surg Pathol. 2016 Sep;40(9):1192-202. doi: 10.1097/PAS.0000000000000662.
4
Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience.胰岛素瘤相关蛋白 1 在细胞学标本中的免疫染色:一项机构经验。
Hum Pathol. 2019 Mar;85:128-135. doi: 10.1016/j.humpath.2018.10.035. Epub 2018 Nov 28.
5
Navigating the diagnostic gray zone: a challenging case of pancreatic high-grade neuroendocrine neoplasm.在诊断的灰色地带中前行:一例具有挑战性的胰腺高级别神经内分泌肿瘤病例。
Diagn Pathol. 2024 Sep 12;19(1):123. doi: 10.1186/s13000-024-01546-6.
6
Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours.SATB2 阳性可将 Islet1 阳性直肠神经内分泌肿瘤与胰十二指肠神经内分泌肿瘤区分开来。
J Clin Pathol. 2021 Sep;74(9):582-588. doi: 10.1136/jclinpath-2020-206645. Epub 2020 Sep 15.
7
Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap.综合基因组和临床病理方法可区分胰腺 3 级神经内分泌肿瘤与神经内分泌癌,并确定一组具有分子重叠的肿瘤。
Mod Pathol. 2023 Mar;36(3):100065. doi: 10.1016/j.modpat.2022.100065. Epub 2023 Jan 10.
8
Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors.胰岛素瘤相关蛋白 1(INSM1)是一种强有力的标志物,可用于鉴定和分级胰腺神经内分泌肿瘤。
Cancer Cytopathol. 2020 Apr;128(4):269-277. doi: 10.1002/cncy.22242. Epub 2020 Jan 24.
9
Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors.在超过 14000 个神经内分泌和非神经内分泌肿瘤中,比较 INSM1 免疫染色与已建立的神经内分泌标志物突触素和嗜铬粒蛋白 A。
Mol Cell Endocrinol. 2024 Feb 1;581:112106. doi: 10.1016/j.mce.2023.112106. Epub 2023 Nov 10.
10
P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.P53、生长抑素受体 2a 和嗜铬粒蛋白 A 免疫染色作为高级胃肠胰神经内分泌肿瘤的预后标志物。
BMC Cancer. 2020 Jan 10;20(1):27. doi: 10.1186/s12885-019-6498-z.

本文引用的文献

1
High expression of insulinoma-associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin.胰岛素瘤相关蛋白1(INSM1)的高表达可将结直肠混合性和纯神经内分泌癌与突触素弥漫性表达的传统腺癌区分开来。
J Pathol Clin Res. 2023 Nov;9(6):498-509. doi: 10.1002/cjp2.339. Epub 2023 Aug 22.
2
Pitx2 is a useful marker of midgut-derived neuroendocrine tumours - an immunohistochemical study of 224 cases.Pitx2 是一种用于诊断肠源神经内分泌肿瘤的有用标志物——224 例免疫组化研究。
Histopathology. 2022 Dec;81(6):799-807. doi: 10.1111/his.14789. Epub 2022 Sep 22.
3
Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker?
传统结直肠癌中的神经内分泌分化:偶然发现还是预后生物标志物?
Cancers (Basel). 2021 Oct 12;13(20):5111. doi: 10.3390/cancers13205111.
4
The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms.高级胃肠胰神经内分泌肿瘤的分子特征。
Endocr Relat Cancer. 2021 Nov 11;29(1):1-14. doi: 10.1530/ERC-21-0152.
5
Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls.胰腺神经内分泌肿瘤:诊断与陷阱。
Virchows Arch. 2022 Feb;480(2):247-257. doi: 10.1007/s00428-021-03211-5. Epub 2021 Oct 13.
6
An analysis of 130 neuroendocrine tumors G3 regarding prevalence, origin, metastasis, and diagnostic features.对 130 例神经内分泌肿瘤 G3 进行分析,涉及患病率、起源、转移和诊断特征。
Virchows Arch. 2022 Feb;480(2):359-368. doi: 10.1007/s00428-021-03202-6. Epub 2021 Sep 9.
7
A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations.196例高级别胃肠胰神经内分泌肿瘤的形态学重新评估共识及其临床相关性
Neuroendocrinology. 2021;111(9):883-894. doi: 10.1159/000511905. Epub 2020 Oct 1.
8
Pancreatic neuroendocrine tumors with somatostatin expression and paraganglioma-like features.具有生长抑素表达及副神经节瘤样特征的胰腺神经内分泌肿瘤
Hum Pathol. 2020 Aug;102:79-87. doi: 10.1016/j.humpath.2020.07.004. Epub 2020 Jul 12.
9
P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.P53、生长抑素受体 2a 和嗜铬粒蛋白 A 免疫染色作为高级胃肠胰神经内分泌肿瘤的预后标志物。
BMC Cancer. 2020 Jan 10;20(1):27. doi: 10.1186/s12885-019-6498-z.
10
The 2019 WHO classification of tumours of the digestive system.2019年世界卫生组织消化系统肿瘤分类。
Histopathology. 2020 Jan;76(2):182-188. doi: 10.1111/his.13975. Epub 2019 Nov 13.